Los síntomas de un raro cáncer de mama que una mujer podría pasar por alto
VIERNES, 14 de octubre de 2022 (HealthDay News) — El cáncer de mama inflamatorio es raro, y tiene algunas señales de advertencia inusuales que muchas mujeres no saben que pueden ser señales de cáncer.Unos expertos del Centro Oncológico Integral de la…
Learn MoreInvasive Breast Cancer Risk Down for Female Child Cancer Survivors
FRIDAY, Oct. 14, 2022 (HealthDay News) — For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 in JAMA Oncology.Tara O. Henderson, M.D., M.P.H., from the University…
Learn MoreSymptoms of a Rare Breast Cancer That Many Women Could Miss
FRIDAY, Oct. 14, 2022 (HealthDay News) — Inflammatory breast cancer is rare and has some unusual warning signs that many women don’t realize can signal the disease.Experts at the Ohio State University Comprehensive Cancer Center shared those symptoms…
Learn MoreRisk Factors for CNS Metastasis ID’d for Inflammatory Breast Cancer
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — Patients with inflammatory breast cancer (IBC), especially those with triple-negative subtype, visceral metastasis, and younger age at metastasis diagnosis, have an increased risk for central nervous system…
Learn MoreBreast Cancer Recurrence Rates Low With Nipple-Sparing Mastectomy
FRIDAY, Oct. 7, 2022 (HealthDay News) — For patients undergoing nipple-sparing mastectomy, overall breast cancer recurrence rates are low at a median follow-up of 10 years, according to a study published in the October issue of Plastic and Reconstruc…
Learn MoreAI Could Improve Diagnostic Accuracy of Breast DCE-MRI
FRIDAY, Oct. 7, 2022 (HealthDay News) — A deep learning (DL) system could improve the diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of breast tissue for detecting breast cancer, according to a study published i…
Learn MoreResponse to Neoadjuvant Chemo for Breast Cancer Varies by Sex
THURSDAY, Oct. 6, 2022 (HealthDay News) — Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to…
Learn MoreLas tasas de mortalidad por el cáncer de mama continúan en descenso en EE. UU.
MARTES, 4 de octubre de 2022 (HealthDay News) — Los investigadores y los profesionales clínicos dedicados al cáncer de mama han logrado un avance inmenso en la reducción de las tasas de mortalidad en las tres últimas décadas, pero en Estados Unidos p…
Learn MoreBreast Cancer Incidence Slowly Increased in Recent Years
TUESDAY, Oct. 4, 2022 (HealthDay News) — The incidence rates of breast cancer have increased slowly and breast cancer mortality rates have declined in recent years, with a persistent racial disparity in breast cancer mortality, according to a report …
Learn More